Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 272-279

  Aramaki, Yo ^a   Mitsuoka, Hirokazu ^a   Toyohara, Masako ^a   Jinnai, Toshikazu ^a   Kanatani, Kazushi ^b   Nakajima, Katsuyuki ^b   Mukai, Eri ^a   Yamada, Yuichiro ^a,c   Kita, Toru ^a   Inagaki, Nobuya ^a   Kume, Noriaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c Department of Internal Medicine ^*  (Japan)

Author keywords

Atherosclerosis; Diabetes mellitus; LOX 1; Remnant lipoproteins; Vascular smooth muscle

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LIPOPROTEIN; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ARTICLE; ATHEROGENESIS; CELL LINE; CELL MIGRATION; CHO CELL; CONTROLLED STUDY; DIABETES MELLITUS; GENETIC TRANSFECTION; HYPERLIPIDEMIA; METABOLIC DISORDER; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; VASCULAR SMOOTH MUSCLE; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ATHEROSCLEROSIS; CATTLE; CELL MOVEMENT; CHOLESTEROL; CRICETINAE; HUMANS; LIPOPROTEINS; MUSCLE CELLS; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCAVENGER RECEPTORS, CLASS E; TRANS-ACTIVATION (GENETICS); TRIGLYCERIDES;

EID: 43949103422     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.017     Document Type: Article

References (30)

1. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease, the Framingham study. JAMA 41 (1979) 2035-2038
2. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NECP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 year and older. Diabetes 52 (2003) 1210-1214
3. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels. Clin Chim Acta 223 (1993) 53-71
4. Nakamura T., and Kugiyama K. Triglycerides and remnant particles as risk factors for coronary artery disease. Curr Atheroscler Rep 8 (2006) 107-110
5. Fukushima H., Sugiyama S., Honda O., et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol 43 (2004) 2219-2224
6. Masuoka H., and Kamei S. Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels. Intern Med 39 (2000) 540-546
7. Higashi K., Ito T., Nakajima K., et al. Remnant-like particles cholesterol is higher in diabetic patients with coronary artery disease. Metabolism 50 (2001) 1462-1465
8. Kawakami A., Tanaka A., Nakajima K., Shimokado K., and Yoshida M. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res 91 (2002) 263-271
9. Kawakami A., Tanaka A., Chiba T., et al. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation 108 (2003) 2679-2688
10. Kawakami A., Tani M., Chiba T., et al. Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism. Arterioscler Thromb Vasc Biol 25 (2005) 424-429
11. Tomono S., Kawazu S., Kato N., et al. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb 1 (1994) 98-102
12. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
13. Hussain M.M., Maxfield F.R., Mas-Oliva J., et al. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem 266 (1991) 13936-13940
14. Gianturco S.H., Ramprasad M.P., Song R., et al. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor. Arterioscler Thromb Vasc Biol 18 (1998) 968-976
15. Takahashi S., Sakai J., Fujino T., et al. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb 11 (2004) 200-208
16. Sawamura T., Kume N., Aoyama T., et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 386 (1997) 73-77
17. Moriwaki H., Kume N., Sawamura T., et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 18 (1998) 1541-1547
18. Moriwaki H., Kume N., Kataoka H., et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-α. FEBS Lett 440 (1998) 29-32
19. Kataoka H., Kume N., Miyamoto S., et al. Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21 (2001) 955-960
20. Kume N., and Kita T. Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res 94 (2004) 269-270
21. Kume N., Murase T., Moriwaki H., et al. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83 (1998) 322-337
22. Mukai E., Kume N., Hayashida K., et al. Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells. Atherosclerosis 176 (2004) 289-296
23. Aoyama T., Fujiwara H., Masaki T., and Sawamura T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol 31 (1999) 2101-2114
24. Kataoka H., Kume N., Miyamoto S., et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99 (1999) 3110-3117
25. Shin H.K., Kim Y.K., Kim K.Y., Lee J.H., and Hong K.W. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 109 (2004) 1022-1028
26. Park S.Y., Lee J.H., Kim Y.K., et al. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther 312 (2005) 1241-1248
27. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., and Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89 (1992) 507-511
28. Redmond E.M., Cahill P.A., Hirsch M., et al. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase. Thromb Haemost 81 (1999) 293-300
29. Chen M., Narumiya S., Masaki T., and Sawamura T. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J 355 (2001) 289-296
30. Higashiyama S., and Nanba D. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim Biophys Acta 1751 (2005) 110-117